With $354,826 in CMTA funding, the SENSE Trial is an HSN1 clinical trial investigating a potential treatment for hereditary sensory neuropathy type 1, with active participation now complete and final data analysis underway.
Simply CMT
More From Simply CMT
-
Bringing Home The Magic of Camp Footprint
The Footprint Fellowship helps campers with CMT carry the confidence, connection, and authenticity they find at Camp Footprint into their everyday lives.
-
CMTA Camp Footprint Launches Fellowship with ACA Grant
A new year-long program helps campers bring the confidence of camp home